Three-drug regimen may reduce relapse risk after transplant for T-cell malignancies
Three-drug regimen may reduce relapse risk after transplant for T-cell malignancies
About this item
Full title
Three-drug regimen may reduce relapse risk after transplant for T-cell malignancies
Author / Creator
Publisher
Thorofare: SLACK INCORPORATED
Journal title
HEM/ONC today, 2022-04, Vol.23 (5), p.15-15
Language
English
Formats
Publication information
Publisher
Thorofare: SLACK INCORPORATED
Subjects
More information
Alternative Titles
Full title
Three-drug regimen may reduce relapse risk after transplant for T-cell malignancies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2661588299
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2661588299
Other Identifiers
ISSN
1526-0488
How to access this item
Log in as a Library member
